Literature DB >> 23306558

Critical role of presenilin-dependent γ-secretase activity in DNA damage-induced promyelocytic leukemia protein expression and apoptosis.

H Song1, J Hyun Boo, K Ho Kim, C Kim, Y-E Kim, J-H Ahn, G Sun Jeon, H Ryu, D E Kang, I Mook-Jung.   

Abstract

Promyelocytic leukemia (PML) is a major component of macromolecular multiprotein complexes called PML nuclear-bodies (PML-NBs). These PML-NBs recruit numerous proteins including CBP, p53 and HIPK2 in response to DNA damage, senescence and apoptosis. In this study, we investigated the effect of presenilin (PS), the main component of the γ-secretase complex, in PML/p53 expression and downstream consequences during DNA damage-induced cell death using camptothecin (CPT). We found that the loss of PS in PS knockout (KO) MEFs (mouse embryonic fibroblasts) results in severely blunted PML expression and attenuated cell death upon CPT exposure, a phenotype that is fully reversed by re-expression of PS1 in PS KO cells and recapitulated by γ-secretase inhibitors in hPS1 MEFs. Interestingly, the γ-secretase cleavage product, APP intracellular domain (AICD), together with Fe65-induced PML expression at the protein and transcriptional levels in PS KO cells. PML and p53 reciprocally positively regulated each other during CPT-induced DNA damage, both of which were dependent on PS. Finally, elevated levels of PML-NB, PML protein and PML mRNA were detected in the brain tissues from Alzheimer's disease (AD) patients, where γ-secretase activity is essential for pathogenesis. Our data provide for the first time, a critical role of the PS/AICD-PML/p53 pathway in DNA damage-induced apoptosis, and implicate this pathway in AD pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23306558      PMCID: PMC3595490          DOI: 10.1038/cdd.2012.162

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  46 in total

1.  The C-terminal fragment of presenilin 2 triggers p53-mediated staurosporine-induced apoptosis, a function independent of the presenilinase-derived N-terminal counterpart.

Authors:  Cristine Alves da Costa; Mark P Mattson; Karine Ancolio; Frederic Checler
Journal:  J Biol Chem       Date:  2003-01-29       Impact factor: 5.157

2.  p53-Dependent transcriptional control of cellular prion by presenilins.

Authors:  Bruno Vincent; Claire Sunyach; Hans-Dieter Orzechowski; Peter St George-Hyslop; Frédéric Checler
Journal:  J Neurosci       Date:  2009-05-20       Impact factor: 6.167

3.  Presenilin 2 interacts with sorcin, a modulator of the ryanodine receptor.

Authors:  E Pack-Chung; M B Meyers; W P Pettingell; R D Moir; A M Brownawell; I Cheng; R E Tanzi; T W Kim
Journal:  J Biol Chem       Date:  2000-05-12       Impact factor: 5.157

Review 4.  p53 ubiquitination: Mdm2 and beyond.

Authors:  Christopher L Brooks; Wei Gu
Journal:  Mol Cell       Date:  2006-02-03       Impact factor: 17.970

5.  Regulation of p53 activity in nuclear bodies by a specific PML isoform.

Authors:  V Fogal; M Gostissa; P Sandy; P Zacchi; T Sternsdorf; K Jensen; P P Pandolfi; H Will; C Schneider; G Del Sal
Journal:  EMBO J       Date:  2000-11-15       Impact factor: 11.598

6.  gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity.

Authors:  Raymond D Meng; Christopher C Shelton; Yue-Ming Li; Li-Xuan Qin; Daniel Notterman; Philip B Paty; Gary K Schwartz
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

7.  Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation.

Authors:  B Wolozin; K Iwasaki; P Vito; J K Ganjei; E Lacanà; T Sunderland; B Zhao; J W Kusiak; W Wasco; L D'Adamio
Journal:  Science       Date:  1996-12-06       Impact factor: 47.728

8.  Loss of neuronal cell cycle control as a mechanism of neurodegeneration in the presenilin-1 Alzheimer's disease brain.

Authors:  Bilal Malik; Antonio Currais; Ana Andres; Christopher Towlson; Didier Pitsi; Ana Nunes; Michael Niblock; Jonathan Cooper; Tibor Hortobágyi; Salvador Soriano
Journal:  Cell Cycle       Date:  2007-12-06       Impact factor: 4.534

9.  Generation of an apoptotic intracellular peptide by gamma-secretase cleavage of Alzheimer's amyloid beta protein precursor.

Authors:  B Passer; L Pellegrini; C Russo; R M Siegel; M J Lenardo; G Schettini; M Bachmann; M Tabaton; L D'Adamio
Journal:  J Alzheimers Dis       Date:  2000-11       Impact factor: 4.472

10.  Deconstructing PML-induced premature senescence.

Authors:  Oliver Bischof; Olivier Kirsh; Mark Pearson; Koji Itahana; Pier Giuseppe Pelicci; Anne Dejean
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 14.012

View more
  6 in total

1.  The Role of Presenilin-1 in the Excitotoxicity of Ethanol Withdrawal.

Authors:  Marianna E Jung; Daniel B Metzger; Hriday K Das
Journal:  J Pharmacol Exp Ther       Date:  2016-06-08       Impact factor: 4.030

2.  Selective ferroptosis vulnerability due to familial Alzheimer's disease presenilin mutations.

Authors:  Mark A Greenough; Darius J R Lane; Rachelle Balez; Helena Targa Dias Anastacio; Zhiwen Zeng; Katherine Ganio; Christopher A McDevitt; Karla Acevedo; Abdel Ali Belaidi; Jari Koistinaho; Lezanne Ooi; Scott Ayton; Ashley I Bush
Journal:  Cell Death Differ       Date:  2022-04-21       Impact factor: 15.828

3.  Structural Neuroimaging Genetics Interactions in Alzheimer's Disease.

Authors:  Seok Woo Moon; Ivo D Dinov; Jaebum Kim; Alen Zamanyan; Sam Hobel; Paul M Thompson; Arthur W Toga
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

4.  Aβ-induced degradation of BMAL1 and CBP leads to circadian rhythm disruption in Alzheimer's disease.

Authors:  Hyundong Song; Minho Moon; Han Kyoung Choe; Dong-Hee Han; Changhwan Jang; Ahbin Kim; Sehyung Cho; Kyungjin Kim; Inhee Mook-Jung
Journal:  Mol Neurodegener       Date:  2015-03-19       Impact factor: 14.195

5.  Mutational re-modeling of di-aspartyl intramembrane proteases: uncoupling physiologically-relevant activities from those associated with Alzheimer's disease.

Authors:  Anastasia P Grigorenko; Youri K Moliaka; Olga V Plotnikova; Alexander Smirnov; Vera A Nikishina; Andrey Y Goltsov; Fedor Gusev; Tatiana V Andreeva; Omar Nelson; Ilya Bezprozvanny; Evgeny I Rogaev
Journal:  Oncotarget       Date:  2017-05-30

6.  Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals.

Authors:  Mahdi Ghani; Christiane Reitz; Rong Cheng; Badri Narayan Vardarajan; Gyungah Jun; Christine Sato; Adam Naj; Ruchita Rajbhandary; Li-San Wang; Otto Valladares; Chiao-Feng Lin; Eric B Larson; Neill R Graff-Radford; Denis Evans; Philip L De Jager; Paul K Crane; Joseph D Buxbaum; Jill R Murrell; Towfique Raj; Nilufer Ertekin-Taner; Mark Logue; Clinton T Baldwin; Robert C Green; Lisa L Barnes; Laura B Cantwell; M Daniele Fallin; Rodney C P Go; Patrick A Griffith; Thomas O Obisesan; Jennifer J Manly; Kathryn L Lunetta; M Ilyas Kamboh; Oscar L Lopez; David A Bennett; Hugh Hendrie; Kathleen S Hall; Alison M Goate; Goldie S Byrd; Walter A Kukull; Tatiana M Foroud; Jonathan L Haines; Lindsay A Farrer; Margaret A Pericak-Vance; Joseph H Lee; Gerard D Schellenberg; Peter St George-Hyslop; Richard Mayeux; Ekaterina Rogaeva
Journal:  JAMA Neurol       Date:  2015-11       Impact factor: 18.302

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.